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Abstract
Background: The transcription factor p63 plays a pivotal role in the development and maintenance of epithelial 
tissues, including the ocular surface. In an effort to gain insight into the pathogenesis of keratitis caused by HSV-1, we 
determined the expression patterns of the p63 and Bax proteins in the Staatens Seruminstitute Rabbit Cornea cell line 
(SIRC).
Methods: SIRC cells were infected with HSV-1 at various multiplicities and maintained for different periods of time. 
Virus replication was measured by indirect immunofluorescence assay and Western blot analysis. Cell viability was 
determined by MTT assay. The apoptotic response of the infected cells was quantified by ELISA detecting the 
enrichment of nucleosomes in the cytoplasm. Western blot analysis was used to determine the levels of p63 and Bax 
proteins.
Results: Indirect immunofluorescence assays and Western blot analyses demonstrated the presence of HSV-1 
glycoprotein D (gD) in the infected SIRC cell line, and the pattern of gD expression was consistent with efficient viral 
replication. The results of MTT and ELISA assays showed that HSV-1 elicited a strong cytopathic effect, and apoptosis 
played an important role in the demise of the infected cells. Mock-infected SIRC cells displayed the constitutive 
expression of ΔNp63α. The expressions of the Bax-β and TAp63γ isoforms were considerably increased, whereas the 
level of ΔNp63α was decreased in the HSV-1-infected SIRC cells. Experiments involving the use of acyclovir showed 
that viral DNA replication was necessary for the accumulation of TAp63γ.
Conclusion: These data suggest that a direct, virus-mediated cytopathic effect may play an important role in the 
pathogenic mechanism of herpetic keratitis. By disturbing the delicate balance between the pro-survival ΔN and the 
pro-apoptotic TA isoforms, HSV-1 may cause profound alterations in the viability of the ocular cells and in the tissue 
homeostasis of the ocular surface.
Background
The p53 family member p63 has been shown to play a
pivotal role in the homeostatic renewal of epithelial tis-
sues [1-3]. There are six p63 protein isoforms, which can
be expressed from two different promoters, one immedi-
ately preceding the first exon and the second one lying in
the third intron (Fig. 1) [1-8]. Transcription from the first
and second promoters gives rise to TA- or ΔN-amino-
termini of p63, respectively (Fig. 1) [1-8]. The TA iso-
forms possess an N-terminal acidic transactivation
domain, while the ΔNp63 proteins lack this domain (Fig.
1) [1-8]. A great body of experimental evidence indicates
that the TAp63 isoforms can induce cell death through a
canonical p53-responsive DNA binding site [1-12]. In
contrast, the ΔNp63 proteins can act in a dominant nega-
tive manner toward p53-mediated transcriptional activa-
tion [1-12]. Both TA and ΔN transcripts can undergo
alternative splicing, leading to the formation of three C-
terminal variants, denoted α, β and γ, which further
increase the diversity of the p63 proteins (Fig. 1) [1-8].
Several interesting studies have clearly demonstrated that
the ΔNp63α isoform plays an important role in the main-
tenance of the conjunctival and corneal stem cells, while
ΔNp63β and ΔNp63γ contribute to the regulation of cell
differentiation and regeneration in the conjunctiva, lim-
bus and cornea [13-19]. Although the importance of p63
in the homeostasis of the ocular surface is widely
accepted, the effects of infectious agents on the expres-
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Page 2 of 8sion of this transcription factor family have not yet been
investigated in epithelial cells of the eye.
Herpetic keratitis is a vision-threatening viral disease of
the eye that is the major infectious cause of blindness in
the developed countries [20-22]. The causative agent,
Herpes simplex virus 1 (HSV-1) is a member of the Her-
pesviridae family comprising large, enveloped DNA
viruses [23]. Primary herpetic keratitis can develop
directly via 'front-door' route infection by droplet spread,
or via a 'back-door' route, which involves the indirect
spread of HSV-1 to the cornea from a non-ocular site
[20]. HSV-1 infection may affect all three corneal layers,
leading to epithelial, stromal and endothelial keratitis,
respectively. Epithelial keratitis can be characterized by
the appearance of branching dendritiform, or enlarged
geographic ulcers [21]. Stromal keratitis and endothelitis
can result in stromal scarring, thinning, neovasculariza-
tion, severe iridocyclitis and an elevated intraocular pres-
sure [20]. Most cases of corneal ulceration will eventually
resolve, though recurrent infections impair the corneal
function and lead to a vision impairment that may even
necessitate penetrating keratoplasty. Previous studies
have revealed that the mechanism of herpetic keratitis
involves both immune- and virus-mediated cytopatho-
genic processes [24-28]. Whereas the immune processes
involved in the pathogenesis of herpetic ocular surface
diseases have been investigated extensively, the molecular
events implicated in the direct cytopathic action of HSV-
1 remain largely unknown.
In the present study, we examined the effects of HSV-1
on the expression of p63 and the Bcl-2 family member
Bax in an effort to gain a better understanding of the ocu-
lar cytopathogenicity elicited by this virus.
Methods
Cell culture and HSV-1 growth
The Staatens Seruminstitute Rabbit Cornea (SIRC) cell
line, was grown in Dulbecco's modified Eagle's minimal
essential medium (Sigma Chemical Co., St. Louis, MO,
USA) supplemented with 10% fetal calf serum (Gibco/
BRL, Grand Island, NY, USA) at 37°C in a 5% CO2 atmo-
sphere.
The KOS strain of HSV-1 was propagated at a multi-
plicity of infection (MOI) of 0.001 plaque-forming unit
(PFU) per cell in Vero cell cultures for 3 days at 37°C. The
culture fluid of HSV-1-infected Vero cells was harvested,
quantified by plaque assay, stored at -70°C, and used as
the infecting stock of the virus.
For experiments, SIRC cell cultures were inoculated
with HSV-1 at different MOIs. 9-[(2-Hydroxy-
ethoxy)methyl]guanine [Acyclovir (ACG); (Sigma)] was
used at various concentrations when indicated. Every
experiment was repeated at least three times.
Indirect Immunofluorescence assay
Cytospin cell preparations were fixed in methanol-ace-
tone (1:1) for 15 minutes (min) at -20°C. Slides were incu-
bated with a 1:200 dilution of polyclonal rabbit anti-HSV
glycoprotein D (gD) immunoglobulin (Sigma) for 1 h at
37°C. After washing with phosphate-buffered saline
(PBS), the samples were reacted with fluorescein isothio-
cyanate-conjugated anti rabbit antibody (1:160) (Sigma)
and incubated for 1 h at 37°C. After washing with PBS,
the slides were visualized by confocal microscopy. The
ratio of positive to negative cells was determined after
counting 1,000 cells in random fields.
Quantification of cell viability by MTT assay
The viability of HSV-1-infected cells was measured with
the colorimetric MTT [3-(4,5-dimethylthiazol-2-yl)2,5-
diphenyltetrazolium bromide] assay Tox-1 kit (Sigma). In
this assay, SIRC cells were seeded in 96-well plates at a
density of 1 × 104/well. The cultures were infected with
HSV-1 at different MOIs. At 48 h postinfection at 37°C,
10 μl MTT reagent (5 mg/ml) was added to each well.
After 2 h incubation, MTT solvent containing 0.1 M HCl
and isopropanol was added for 15 h. Absorbance was
measured at 545 and 630 nm. The ratio of living cells was
calculated via the following formula: percentage viability
= [(absorbance of infected cells - blank)/(absorbance of
Figure 1 (A) Gene architecture of human p63. The alternative pro-
moters and spicing events used to generate the various p63 isoforms 
are indicated. (B) Domain structure of the various p63 proteins. The 
transcription activation domain (TAD), DNA binding domain (DBD), oli-
gomerisation domain (OD), sterile α motif (SAM) and the transinhibitor 
domain (TID) are depicted. The molecular size of each isoform is indi-
cated on the right. (Not drawn to scale; adapted from [2-7]). aa, amino 
acid
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100.
Quantification of apoptosis by enzyme-linked 
immunosorbent assay (ELISA)
The cells were washed in phosphate buffered saline (PBS)
and the cell pellet was processed in a cell death detection
ELISA kit (Roche Diagnostics GmbH, Penzberg, Ger-
many) based on the measurement of histones complexed
with mono- and oligonucleosome fragments formed dur-
ing cell death. For this assay, the cells were incubated in
lysis buffer for 30 minutes (min) and centrifuged at
12,000 rpm for 10 min. The supernatants were trans-
ferred into a streptavidin-coated microplate and incu-
bated with biotin-conjugated anti-histone and
peroxidase-conjugated anti-DNA monoclonal antibodies
for 2 h. After washing, substrate solution 2,2'-azino-bis(3-
ethylbenzthiazoline-6-sulphonic acid) (ABTS) was added
to each well for 15 min. Absorbance was measured at 405
and 490 nm. The specific enrichment of mono- and oligo-
nucleosomes was calculated as enrichment factor (EF) =
absorbance of HSV-1-infected cells/absorbance of corre-
sponding non-infected control cells.
Western blot assays
Cells (1 × 107) were homogenized in ice-cold lysis buffer
containing 150 mM NaCl, 10 mM Tris HCl, pH 7.6, 5
mM EDTA, 1% (v/v) Nonidet P-40, 0.1% SDS, 1% sodium
deoxycholate and protease inhibitor cocktail (Sigma), and
the mixture was then centrifuged at 10,000 g for 10 min to
remove cell debris. Protein concentrations of cell lysates
were determined by using the Bio-Rad protein assay (Bio-
Rad, Hercules, CA, USA). Supernatants were mixed with
Laemmli's sample buffer and boiled for 3 min. Aliquots of
the supernatants, containing 50 μg of total protein to
detect p63, HSV D glycoprotein (gD) and Bax, were
resolved by SDS-PAGE and electrotransferred onto nitro-
cellulose filters (Amersham, Buckinghamshire, UK). Pre-
blocked blots were reacted with specific antibodies to
HSV gD (Sigma), p63 detecting all of the various p63 iso-
forms (clone 4A4) (Santa Cruz Biotechnology Inc., Cam-
bridge, MA, USA), p40 detecting the ΔNp63 isoforms
(Merck KGaA, Darmstadt, Germany) and Bax (PharMin-
gen, SanDiego, CA, USA) for 4 h in PBS containing 0.05%
(v/v) Tween 20, 1% (w/v) dried non-fat milk (Difco Labo-
ratories, Detroit, MI, USA) and 1% (w/v) BSA [fraction V;
(Sigma)]. Blots were then incubated for 2 h with species-
specific secondary antibodies coupled to peroxidase [per-
oxidase-conjugated anti-mouse antibody (DakoCytoma-
tion, Carpinteria, CA, USA), or peroxidase-conjugated
anti-rabbit antibody (DakoCytomation)]. Filters were
washed five times in PBS-Tween for 5 min after each step
and were developed by using a chemiluminescence detec-
tion system (Amersham). The autoradiographs were
scanned with a GS-800 densitometer (Bio-Rad), and the
relative band intensities were quantified by use of the
ImageQuant software (Amersham).
Statistical analysis
All values are expressed as means ± standard deviation
(SD). The one-way ANOVA test with the Bonferroni
post-test was used for pairwise multiple comparisons,
and P values < 0.05 were considered statistically signifi-
cant.
Results
HSV-1-infected SIRC cells exhibit gD expression and 
increased apoptotic rates
The SIRC cell line was infected with the KOS strain of
HSV-1 at various multiplicities and maintained for differ-
ent periods of time.
Indirect immunofluorescence assays to evaluate HSV-1
replication revealed positive staining for gD at 48 h
postinfection (hpi) in ≥ 99% of SIRC cells infected at an
MOI of 1 (Fig. 2).
MTT assays to evaluate the cytopathogenicity of HSV-1
revealed decreased viability at 48 hpi in 23 and 36% of
SIRC cells infected at MOIs of 1 and 10, respectively (Fig.
3).
ELISA to evaluate the extent of apoptosis revealed
increased apoptotic rates in HSV-1-infected SIRC cells at
48 hpi; the EFs measured at MOIs of 0.1, 1 and 10 were
1.42, 4.35 and 5.8, respectively (Fig. 3).
Together, these data demonstrate the expression of
HSV-1 gD protein that is consistent with efficient viral
replication. Moreover, these results reveal that HSV-1
elicits a strong cytopathic effect in the SIRC cell line, and
apoptosis plays an important role in the demise of the
infected cells.
Figure 2 Replication of HSV-1 in the SIRC cell line. SIRC cells were 
infected with the KOS strain of HSV-1 at an MOI of 1 for 48 h (B). Mock-
infected SIRC cells cultured in parallel were left untreated (A). HSV-1 
replication was examined by confocal microscopy after staining with 
an HSV gD protein-specific rabbit polyclonal antibody preparation and 
FITC-conjugated anti-rabbit immunoglobulin. Results are representa-
tive of three independent experiments.
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To determine whether HSV-1 can alter the expressions of
Bax and p63, the steady-state levels of these proteins were
determined by Western blot analysis.
First, the kinetics of HSV-1 gD expression was investi-
gated. The presence of gD was observed in the SIRC cell
cultures infected with HSV-1 at an MOI of 10 at 12 hpi
(Fig. 4; lane 20). The gD protein accumulated in the cul-
tures infected with HSV-1 at MOIs of 0.1, 1 and 10 at 24
hpi (Fig. 4; lanes 23-25). High-level expression of the gD
protein was also revealed in every culture infected with
HSV-1 by 48 hpi (Fig. 4; lanes 27-30).
The analysis revealed the presence of a Bax isoform
corresponding to Bax-β in HSV-1-infected SIRC cultures
at 12 hpi (the relative quantity of Bax-β in cells infected at
an MOI of 10 was 1.67) (Fig. 4; lane 20). At the 24-h time
point, the expression of the Bax-β protein in the HSV-1-
infected SIRC cultures was upregulated (the relative
quantities of Bax-β in cells infected at MOIs of 1 and 10
were 6.42 and 8.31, respectively) (Fig. 4; lanes 24 and 25).
At the 48-h time point, the HSV-1-infected SIRC cultures
displayed elevated levels of Bax-β (the relative quantities
of Bax-β in cells infected at MOIs of 0.01, 0.1, 1 and 10
were 9.27, 9.93, 7.57 and 6.62, respectively) (Fig. 4; lanes
27-30).
The expression pattern of p63 was determined by using
an antibody preparation which recognizes all of the vari-
ous p63 isoforms. The analysis revealed the constitutive
expression of a p63 protein migrating near 68 kDa in the
mock-infected SIRC cells (lanes 1, 6, 11, 16, 21 and 26 in
Fig. 4). Previously published data demonstrated that the
68 kDa protein possibly corresponds to ΔNp63α [4]. At
12 hpi, the expression of ΔNp63α in the HSV-1-infected
SIRC cultures was downregulated (the relative quantity of
ΔNp63α in cells infected at an MOI of 10 was 0.87) (Fig.
4; lane 20). At the 24-h time point, HSV-1 triggered an
impressive reduction in the level of ΔNp63α in the SIRC
cells (the relative quantities in cells infected at MOIs of
0.01, 0.1, 1 and 10 were 0.89, 0.43 and 0.41, respectively)
(Fig. 4; lanes 23-25). At the 48-h time point, the HSV-1-
infected SIRC cultures exhibited decreased levels of
ΔNp63α (the relative quantities in cells infected at MOIs
of 0.01, 0.1, 1 and 10 were 0.36, 0.22, 0.19 and 0.17,
respectively) (Fig. 4; lanes 27-30).
The experiments also revealed the presence of a 51-62
kDa protein in HSV-1-infected SIRC cultures. Previously
published data demonstrated that the 51-62 kDa protein
possibly corresponds to TAp63γ [4]. At 12 hpi, HSV-1-
infected SIRC cells exhibited increased levels of TAp63γ
(the relative quantity of TAp63γ in cells infected at an
MOI of 10 was 48.6) (Fig. 4; lane 20). At the 24-h time
point, the expression of TAp63γ in the HSV-1-infected
SIRC cultures was highly upregulated (the relative quan-
tities in cells infected at MOIs of 0.1, 1 and 10 were 4.5,
78.1 and 82.4) (Fig. 4; lanes 23-25). At 48-h postinfection,
the HSV-1-infected SIRC cultures displayed elevated lev-
els of TAp63γ (the relative quantities in cells infected at
MOIs of 0.01, 0.1, 1 and 10 were 81.8, 77.5, 75.6 and 63.4,
respectively) (Fig. 4; lanes 27-30).
To identify the p63 isoforms, the steady-state levels of
these proteins were determined by Western blot analysis,
using a polyclonal antiserum which reacts only with the
Figure 3 HSV-1 induces cell death in the SIRC cell line. SIRC cells 
were infected with HSV-1 at different MOIs for 48 h. Mock-infected cells 
cultured in parallel were left untreated. The cell viability was measured 
by using the MTT assay (A). Apoptosis was detected by measuring the 
specific enrichment of mono- and oligonucleosomes in the cytoplasm 
by ELISA (B). The enrichment factor was calculated as the absorbance 
of HSV-1-infected cells/absorbance of corresponding non-infected 
control cells. Data are mean (± SD) values from four independent ex-
periments. P values were calculated by the ANOVA test with the Bon-
ferroni post-test. aP < 0.001 vs. mock; bP < 0.001 vs. 0.1 MOI; cP < 0.001 
vs. 1 MOI; ns = nonsignificant vs. mock.
Figure 4 HSV-1 infection alters the levels of p63 and Bax-β in the 
SIRC cell line. Total protein was isolated from mock-infected cells and 
from cultures infected with HSV-1 at MOIs of 0.001, 0.01, 0.1, 1 and 10 
at the indicated time points. Samples were resolved on SDS-PAGE and 
transferred onto nitrocellulose filters. The steady-state levels of gD, 
Bax-α, Bax-β and p63 were analyzed by Western blot assay. To deter-
mine protein levels in HSV-1-infected cells, band intensities were quan-
tified by use of the ImageQuant software. The numbers indicate the 
relative quantities of each band, normalized to the control cells at each 
time point. Lanes 1, 6, 11, 16, 21 and 26, mock-infected cells; lanes 2-5, 
7-10, 12-15, 17-20, 22-25 and 27-30, HSV-1-infected cultures. The re-
sults are representative of three independent experiments.
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detected the 68 kDa p63 isoform in the mock-infected
SIRC cells, but failed to recognize the 51-62 kDa p63 iso-
form in the cultures infected with HSV-1 at an MOI of 10
for 24 hpi (Fig 5). These results clearly reveal that the 68
kDa p63 protein detected in the mock-infected SIRC cells
is ΔNp63α, while the 51-62 kDa p63 isoform detected in
HSV-1-infected cultures is TAp63γ.
Together, these results indicate that HSV-1 modulates
the expression patterns of Bax and p63. The level of
ΔNp63α was decreased, while the expressions of Bax-β
and TAp63γ were highly increased in the HSV-1-infected
SIRC cells.
HSV-1-mediated TAp63γ expression requires viral DNA 
replication
To investigate the basis of the HSV-1-induced increase of
the TAp63γ level, SIRC cells were infected in the presence
or absence of the viral DNA replication inhibitor ACG.
The cells were analyzed for the presence of HSV gD,
ΔNp63α, TAp63γ and Bax-β. The low level of the late
protein gD expression in SIRC samples treated with 50 or
10 μg/ml ACG indicated that the drug treatment effi-
ciently inhibited viral DNA replication (Fig. 6; lanes 2 and
3).
The Bax-β protein levels in the HSV-1-infected SIRC
cells treated with 50, 10 and 1 μg/ml ACG were greatly
decreased (the relative quantities of Bax-β in cells
infected at an MOI of 10 were 0.12, 0.15 and 0.21, respec-
tively) (Fig. 6; lanes 2-4).
The TAp63γ protein levels in the HSV-1-infected SIRC
cells treated with 50 and 10 μg/ml ACG were greatly
decreased (the relative quantities of TAp63γ in cells
infected at an MOI of 10 were 0.11 and 0.19) (Fig. 6; lanes
2 and 3). The expression of the TAp63γ isoform in the
HSV-1-infected cultures treated with 1 μg/ml ACG was
downregulated (the relative quantity of TAp63γ in SIRC
cells infected at an MOI of 10 was 0.24) (Fig. 6; lane 4).
Discussion
This study, aiming to evaluate the role of p63 in the
pathogenic mechanisms of herpetic ocular surface dis-
ease, revealed the presence of HSV-1 gD protein and a
Figure 6 The HSV-1-mediated TAp63γ expression requires viral 
DNA replication. SIRC cells were infected with the KOS strain of HSV-
1 at an MOI of 10 and maintained for 24 h in the absence or in the pres-
ence of Acyclovir (ACG). To determine the dependence of the TAp63γ 
expression on HSV-1 DNA replication, the levels of gD, Bax and p63 
were determined by Western blot assay. To determine protein levels in 
HSV-1-infected cells, band intensities were quantified by densitometric 
analysis with the Imagequant software. The numbers indicate the rela-
tive quantities of each band, normalized to the control cells at each 
time point. Lane 1: HSV-1-infected cells incubated in the absence of 
ACG; lanes 2-4: HSV-1-infected cells incubated in the presence of ACG. 
The results are representative of three independent experiments.
Figure 5 Serological identification of the p63 isoforms expressed 
in HSV-1-infected SIRC cells. The levels of different p63 isoforms 
were detected at 24 hpi in mock-infected and HSV-1-infected SIRC 
cells by Western blot analysis, using an antibody preparation that rec-
ognizes all of the various p63 isoforms (lanes 1 and 2) and a ΔN-iso-
form-specific immunoglobulin (lanes 3-7).
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neal cell line (SIRC) (Figs 2, 3, 4). Our data have also indi-
cated that apoptosis plays an important role in the demise
of SIRC cells infected with HSV-1 (Fig. 3). These data are
in full agreement with previous findings demonstrating
that HSV-1 has the potential to elicit various forms of cell
death, including necrosis, apoptosis, anoikis and
autophagy [29-35].
Compelling evidence has accumulated that the various
p63 isoforms play pivotal roles in several physiological
and pathological processes of the ocular surface [13-19].
The ΔN and TA p63 subclasses operate in a concerted
fashion to maintain the proliferative potential of the ocu-
lar surface epithelia and to control the processes of differ-
entiation and regeneration in the conjunctiva and cornea
[15,19]. The ocular surface may be exposed to harmful
environmental stimuli, such as ultraviolet exposure, and
may also function as an entry site for a wide array of
human pathogenic microorganisms. By disturbing the
delicate balance between the pro-survival ΔN and the
pro-apoptotic TA isoforms, stress signals that alter the
expression of p63 may cause profound alterations in the
viability of the ocular cells and in the tissue homeostasis
of the ocular surface. As a step in our investigations of the
underlying molecular events implicated in HSV-1-
induced ocular cytopathogenicity, we focused on the role
of p63 in the SIRC cell line. Our experiments revealed the
constitutive expression of ΔNp63α in the mock-infected
SIRC cells (Fig. 4). Interestingly, we observed an impres-
sive reduction in the level of the ΔNp63α and a dramatic
rise in the level of TAp63γ following infection with HSV-
1 (Fig. 4). The kinetics of HSV-1 replication and the level
of TAp63γ expression correlated strictly (Fig. 4). Note-
worthy previous studies raise the possibility that HSV-1
may alter the expression of p63 via multiple mechanisms
[36-45]. Certain viral proteins may have the potential to
alter the transcription of p63 or to affect the stability and
activity of the p63 isoforms via the induction of their
posttranslational modifications [36-44]. The virion-asso-
ciated host shutoff protein [(vhs), also known as UL41],
which causes the degradation of cellular and viral RNA
[36,37], may evoke a decrease in the level of ΔNp63α
mRNA. The α-trans-inducing factor [(α-TIF), also known
as VP16 or UL48], which stimulates the transcription of
IE genes via cellular transcription factors, such as the
POU homeodomain protein Oct-1 (where Oct stands for
octamer binding protein) and the host cell factor [38-40],
may elicit an increase in the level of TAp63γ. The infected
cell protein (ICP) 0, which controls the stability of cellular
proteins and leads to the disruption of promyelocytic leu-
kemia (PML) nuclear bodies [also known as PODs (PML
oncogenic domains) and ND10 (nuclear domain 10)] [41-
44], may dysregulate the expression pattern of p63. How-
ever, interesting studies have demonstrated that the repli-
cation of HSV-1 DNA activates the ataxia teleangiectasia
mutated (ATM)-dependent signaling pathway implicated
in the cellular DNA damage response (DDR) [45]. Since
TAp63 isoforms have been shown to operate as impor-
tant downstream mediators of DDR [46-48], it is conceiv-
able that the dysregulation of p63 expression observed in
HSV-1 infected SIRC cells is a result of the activation of
DDR evoked by viral replication. Our experiments have
shown that the viral DNA replication inhibitor ACG
completely abolished the HSV-1-mediated induction of
TAp63γ in SIRC cells, indicating that replication of viral
DNA is necessary for the accumulation of TAp63γ (Fig.
6). This observation strongly supports the view that the
dysregulation of p63 expression depends on the cellular
DDR, but does not exclude the role of HSV-1-encoded
proteins. Thus, additional studies are required to eluci-
date the potential contributions of vhs, α-TIF, ICP0 and
other viral proteins to the development of the HSV-1-
mediated dysregulation of p63 expression. Our data fur-
ther demonstrated that HSV-1-infected SIRC cells display
decreased viability and an increased apoptotic rate (Fig.
3). Together, these results suggest that the altered pattern
of p63 expression observed in HSV-1-infected SIRC cells
may represent a mechanism by which this virus perturbs
the functions of the corneal epithelial cells and leads to
their demise.
In line with these data, we next investigated the expres-
sion of Bax, which is known to be upregulated by TAp63α
and TAp63γ [10,11]. Previous studies have demonstrated
the existence of several Bax isoforms [49]. It is well docu-
mented that Bax-α is a central component of apoptosis
induction [50]. In response to apoptotic stimuli, Bax-α
becomes activated, translocates to the mitochondria and
triggers the release of cytochrome c and caspase-9, which
in turn results in the irreversible execution of the apop-
totic program [51]. It has been reported that the Bax-β
protein is expressed constitutively in several human cell
types, and its level is controlled by proteasomal degrada-
tion [52]. Various stressors inhibit ubiquitination of the
Bax-β protein and thereby prevent its proteasomal degra-
dation, leading to the accumulation of this Bax isoform
[52]. Similarly to Bax-α, Bax-β has the capability to trig-
ger apoptosis via the mitochondrial pathway [52,53].
Moreover, Bax-β associates with and promotes Bax-α
activation [53]. Our experiments revealed no constitutive
expression of any of the Bax isoforms in the mock-
infected SIRC cells (Fig. 4). Interestingly, we observed a
dramatic rise in the level of Bax-β in HSV-1-infected cul-
tures (Fig. 4). Following the demonstration of an altered
Bax expression pattern in SIRC cells, we postulate an
important role for Bax-β in the apoptotic responsiveness
of corneal epithelial cells infected with HSV-1. Other
interesting recent data have proved that HSVs encode
ubiquitinating and deubiquitinating enzymes, which can
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cell proteins [54,55]. In view of these observations, it is
reasonable to infer that the Bax-β protein may be a novel
target of HSV-1-mediated deubiquitinating events. How-
ever, the precise molecular mechanisms responsible for
stabilization of the Bax-β protein in HSV-1-infected cells
remain to be elucidated.
Conclusions
Overall, this study demonstrates that the KOS strain of
HSV-1 modulates the patterns of p63 and Bax expression
in the SIRC cell line. These data may bear on the patho-
genic mechanisms of ocular diseases caused by HSV-1, as
p63 and Bax isoforms play a pivotal role in the mainte-
nance of the ocular surface integrity.
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